Platelet function study in patients with sepsis
Part of Infections clinical trials.
This study looks at how platelets (small cells that help blood clot) behave in people with severe infections (sepsis). It explores a specific part of the immune system (inflammasome) linked to platelet activation, which may help develop better treatments for serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You (or a family member or legal representative) must agree to participate
- For most groups, you must have a confirmed infection (sepsis) with a positive lab test for bacteria or virus
- For one group, you must not have any infection (this group acts as a comparison)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether platelet counts (a type of blood cell that helps clotting) can predict how likely a patient is to survive sepsis. If you are hospitalized with sepsis, your platelet levels may be measured to see if they can help doctors know who needs more intensive care.
This study looks at whether platelet transfusions help patients with sepsis and very low platelet counts recover better. If you or your loved one had sepsis, a low platelet count, and were in the ICU for at least two days, this trial may be relevant.
This trial tests a drug called romiplostim to see if it can safely raise platelet counts in people with sepsis (a severe infection that can cause organ damage). If you have low platelets due to sepsis, this treatment might help reduce bleeding risks.
This study looks at how special cells from bone marrow (called stem cells) might help fix immune problems caused by sepsis. The goal is to see if these cells can improve how your immune system works during a severe infection.
This study is testing a blood test that may help doctors diagnose sepsis faster. It involves people with sepsis and healthy volunteers to compare results.
This trial is testing whether certain markers in your blood or other samples can help doctors diagnose sepsis (a severe infection that affects your organs) more quickly. If you join, the study will use samples already collected to look for these markers, which might lead to faster treatment for future patients.
Hear when a new Bacterial Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.